Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Safety and Clinical Performance of the Next-Generation SAFESYNC Transcatheter Heart Valve in Patients With Severe Aortic Stenosis

The objective of this pivotal, prospective, multicenter, single-arm clinical trial is to evaluate the safety and clinical performance of the Next-Generation INOVARE® SAFESYNC Bioprosthetic Heart Valve, implanted via a transcatheter approach, in patients with severe aortic stenosis, an indication for TAVI, and intermediate or higher surgical risk. The study will enroll 40 participants.

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Braile Biomedica Ind. Com. e Repr. Ltda.Updated: Sep 8, 2026
Eligibility criteria

Severe aortic valve stenosis diagnosed according to criteria established in curr... [+3]

Any condition considered a contraindication to implantation of a bioprosthetic h... [+17]

Status: Recruiting

Clinical Performance of the VESTO® Vascular Stent for Treatment of Iliac Peripheral Obstructive Arterial Disease

This study will validate the efficacy and safety of the VESTO® Vascular Stent for treating patients with iliac peripheral arterial obstructive disease in a post-market clinical trial

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Braile Biomedica Ind. Com. e Repr. Ltda.Updated: Mar 26, 2025Locations: 6
Eligibility criteria

18 years of age or older; [+6]

Known hypersensitivity to heparin, contrast media, or stent components; [+8]

Status: Recruiting

Post-market Clinical Trial of the Dominus® Stent-Graft

Real-world clinical trial evidence post-market, evaluating the safety and efficacy of the Dominus® StentGraft Endoprosthesis in treating thoracic aortic diseases, following the Instructions for Use

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Braile Biomedica Ind. Com. e Repr. Ltda.Updated: Aug 22, 2024Locations: 3
Eligibility criteria

18 years of age or older; [+3]

Patient currently participating in another clinical study of drug or medical dev... [+1]